1. bookVolume 51 (2017): Issue 1 (January 2017)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Open Access

Factors associated with increased irisin levels in the type 1 diabetes mellitus

Published Online: 17 Feb 2017
Volume & Issue: Volume 51 (2017) - Issue 1 (January 2017)
Page range: 1 - 7
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objective. The aim of the present study was to determine the irisin levels in patients with the type 1 diabetes mellitus (T1DM) and to examine the relation of irisin levels with the inflammation and autoimmunity.

Methods. This study included 35 cases diagnosed with T1DM and 36 healthy volunteers. Antiglutamic acid decarboxylase (anti-GAD), islet cell antibody (ICA), and insulin autoantibody levels were measured in patients at the time when they were included into the study and recorded from the patient files. Serum irisin levels were measured by ELISA kit.

Results. The median irisin levels were determined higher in T1DM group compared to the control one (6.8 ng/ml vs. 4.8 ng/ml, p=0.022; respectively). Median irisin levels were higher in anti-GAD (p=0.022) and ICA (p=0.044) positive groups compared to negative groups. In T1DM group, irisin levels displayed positive correlation with glycosylated hemoglobin (HbA1c) (r=0.377, p<0.001) and anti-GAD (r=0.392, p=0.020) and negative correlation with creatinine (r=-0390, p=0.021). In multivariate regression model, HbA1c (B±SE: 2.76±17683, p<0.001), and anti-GAD (B±SE: 2.311±0.610, p=0.001) were determined as independent predictors for predicting the irisin levels.

Conclusion. In patients with T1DM, which chronic inflammation and autoimmunity take part in their etiopathogenesis, anti-GAD levels were an independent risk factor for the irisin. Th is may suggest that factors such as inflammation and autoimmunity can be effective in the synthesis of irisin.

Keywords

Affourtit C, Quinlan CL, Brand MD. Measurement of proton leak and electron leak in isolated mitochondria. Methods Mol Biol 810, 165-182, 2012.10.1007/978-1-61779-382-0_11Search in Google Scholar

Ates I, Altay M, Topcuoglu C, Yilmaz FM. Circulating levels of irisin is elevated in hypothyroidism, a case-control study. Arch Endocrinol Metab 60, 95-100, 2016.10.1590/2359-3997000000077Search in Google Scholar

Aydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides 56, 94-110, 2014.10.1016/j.peptides.2014.03.021Search in Google Scholar

Aydin S, Kuloglu T, Aydin S, Kalayci M, Yilmaz M, Cakmak T, Albayrak S, Gungor S, Colakoglu N, Ozercan IH. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 61, 130-136, 2014.10.1016/j.peptides.2014.09.014Search in Google Scholar

Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468, 2012.10.1038/nature10777Search in Google Scholar

Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100, 96-101, 2013.10.1016/j.diabres.2013.01.007Search in Google Scholar

Crujeiras AB, Pardo M, Arturo RR, Navas-Carretero S, Zulet MA, Martinez JA, Casanueva FF. Longitudinal variation of circulating irisin aft er an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol 26, 198-207, 2014.10.1002/ajhb.22493Search in Google Scholar

De Naeyer H, Ouwens DM, Van Nieuwenhove Y, Pattyn P, Hart LM, Kaufman JM, Sell H, Eckel J, Cuvelier C, Taes YE, Ruige JB. Combined gene and protein expression of hormone-sensitive lipase and adipose triglyceride lipase, mitochondrial content, and adipocyte size in subcutaneous and visceral adipose tissue of morbidly obese men. Obes Facts 4, 407-416, 2011.10.1159/000333445Search in Google Scholar

Enerback S. Brown adipose tissue in humans. Int J Obes (Lond) 34 Suppl 1, S43-46, 2010.10.1038/ijo.2010.183Search in Google Scholar

Espes D, Lau J, Carlsson PO. Increased levels of irisin in people with long-standing Type 1 diabetes. Diabet Med 32, 1172-1176, 2015.10.1111/dme.12731Search in Google Scholar

Febbraio MA. Exercise and infl ammation. J Appl Physiol (1985) 103, 376-377, 2007.10.1152/japplphysiol.00414.2007Search in Google Scholar

Handschin C. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha in muscle links metabolism to infl ammation. Clin Exp Pharmacol Physiol 36, 1139-1143, 2009.10.1111/j.1440-1681.2009.05275.xSearch in Google Scholar

Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725-1738, 2012.10.1016/j.metabol.2012.09.002Search in Google Scholar

Jastroch M, Divakaruni AS, Mookerjee S, Treberg JR, Brand MD. Mitochondrial proton and electron leaks. Essays Biochem 47, 53-67, 2010.10.1042/bse0470053Search in Google Scholar

Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 27, 365-369, 2013.10.1016/j.jdiacomp.2013.03.002Search in Google Scholar

Liu JJ, Liu S, Wong MD, Tan CS, Tavintharan S, Sum CF, Lim SC. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications 28, 208-213, 2014.10.1016/j.jdiacomp.2013.09.011Search in Google Scholar

Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernandez-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98, E769-778, 2013.10.1210/jc.2012-2749Search in Google Scholar

Park KH, Zaichenko L, Peter P, Davis CR, Crowell JA, Mantzoros CS. Diet quality is associated with circulating Creactive protein but not irisin levels in humans. Metabolism 63, 233-241, 2014.10.1016/j.metabol.2013.10.011Search in Google Scholar

Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24, 113-119, 2003.10.1023/A:1026070911202Search in Google Scholar

Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, Perticone F. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol 51, 705-713, 2014.Staiger H, Bohm A, Scheler M, Berti L, Machann J, Schick F, Machicao F, Fritsche A, Stefan N, Weigert C, Krook A, Haring HU, de Angelis MH. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived ‘browning’ factor irisin, determines insulin sensitivity. PLoS One 8, e61903, 2013.10.1371/journal.pone.0061903Search in Google Scholar

Wen MS, Wang CY, Lin SL, Hung KC. Decrease in irisin in patients with chronic kidney disease. PLoS One 8, e64025, 2013.10.1371/journal.pone.0064025Search in Google Scholar

Yan B, Shi X, Zhang H, Pan L, Ma Z, Liu S, Liu Y, Li X, Yang S, Li Z. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One 9, e94235, 2014. 10.1371/journal.pone.0094235Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo